Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Medicure Inc V.MPH

Alternate Symbol(s):  MCUJF

Medicure Inc. is a pharmaceutical company. It is focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market. The focus of it is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through the Company... see more

TSXV:MPH - Post Discussion

Medicure Inc > According to case reports, treatment with PLP can prevent
View:
Post by Checkout on Jul 10, 2024 5:28pm

According to case reports, treatment with PLP can prevent

 2) May Be Better for Some Forms of Vitamin B6-Dependent Seizures The lack of vitamin B6 can cause severe neurological damage right after birth; it usually results in seizures, known as vitamin B6-dependent epilepsy. Intravenous pyridoxine is the treatment of choice and can be lifesaving [56, 57, 58]. A rare subtype of this disorder is so-called PLP-dependent epilepsy. It occurs due to mutations in the pyridoxine-5’-phosphate oxidase (PNPO). These patients require large doses of PLP as the liver can’t produce it from pyridoxine [64, 65]. According to multiple case reports, prompt treatment with PLP can prevent permanent brain damage and death [66, 65, 67]. Some authors have successfully treated other types of seizures with vitamin B6, and they have reported better results with PLP compared with pyridoxine [58, 68]. We can’t make conclusions based on these case reports. Further studies should evaluate the safety and efficacy of PLP for vitamin B6-dependent seizures.
Comment by Checkout on Jul 10, 2024 5:31pm
if we get FDA approval we also recieve a fast track voucher worth 100 - 200 million dollars.  The lack of vitamin B6 can cause severe neurological damage right after birth; it usually results in seizures, known as vitamin B6-dependent epilepsy. Intravenous pyridoxine is the treatment of choice and can be lifesaving [56, 57, 58]. A rare subtype of this disorder is so-called PLP-dependent ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities